"Asthma Bhawan is the leading center for Lung, Allergy, OSA, ILD, COPD, EBUS Treatments. Consult with our experts and get best Advice. BOOK APPOINTMENT NOW"

During the past decade, Asthma Bhawan conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Asthma Bhawan" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Lung Diseases, Interstitial" (1 trials) and "Scleroderma, Systemic" (1 trials). Many other conditions were trialed in "Asthma Bhawan" in a lesser frequency.

Most popular intervention types in "Asthma Bhawan" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Nintedanib" (3 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asthma Bhawan" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Asthma Bhawan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Asthma Bhawan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asthma Bhawan, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".